Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201110201 Principal Investigator: Roth, Bruce
Title: A Randomized, Double-blind Phase 2 Study Comparing Gemcitabine and Cisplatin in Combination with OGX-427 or Placebo in Patients with Advanced Transitional Cell Carcinoma
Phase: II Disease Site: Bladder
Participating Site(s):
 
Main Campus
Map and Directions		 South County
Map and Directions		 West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this research study is to find out if treatment with gemcitabine, cisplatin and study drug (OGX-427) can increase survival in subjects with TCC compared to gemcitabine, cisplatin and placebo.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)